Halogenated agents and cardiovascular surgery: Has mortality really decreased?

G Landoni, JC Lopez-Delgado, C Sartini, S Tamà, A Zangrillo

Research output: Contribution to journalArticlepeer-review

Abstract

Halogenated anesthetic agents (desflurane, isoflurane and sevoflurane) may have cardioprotective properties at therapeutic doses against myocardial intraoperative ischemia-reperfusion injury. Cardioprotection mechanisms are related to mitochondrial and anti-apoptotic signaling pathways. Ex-perimentals and human studies have proven that their use may reduce morbidity and mortality in the setting of cardiac surgery, including a reduction in myocardial infarct size and mechanical ventilation needs. In contrast, total intra-venous propofol based anesthesia may be detrimental. In the present review, we show the rationale for the perioperative use of halogenated anesthetics based on mechanisms of action, experimental research and human studies. Considerations and major concerns regarding their use, the present evidence for their use in other areas, such as major non-cardiac surgery and intensive care unit patients, and future perspectives are also discussed. © 2018 Bentham Science Publishers.
Original languageEnglish
Pages (from-to)336-343
Number of pages8
JournalCurrent Vascular Pharmacology
Volume16
Issue number4
DOIs
Publication statusPublished - 2018

Fingerprint Dive into the research topics of 'Halogenated agents and cardiovascular surgery: Has mortality really decreased?'. Together they form a unique fingerprint.

Cite this